Potential for Increasing Uptake of Radiolabeled 68Ga-DOTATOC and 123I-MIBG in Patients with Midgut Neuroendocrine Tumors Using a Histone Deacetylase Inhibitor Vorinostat

Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print.

Source: Cancer Biotherapy and Radiopharmaceuticals - July 12, 2021 Category: Cancer & Oncology Authors: Janet H. Pollard Yusuf Menda K.D. Zamba Mark Madsen M. Sue O'Dorisio Thomas O'Dorisio David Bushnell Source Type: research